BackDynavax Technologies Overview

Dynavax Technologies Long Term Debt

Track Dynavax Technologies's long-term debt ($240M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$244.95M
2.09% YoYΔ $-5.22M vs prior year quarter

Peer average / median

Loading

Dynavax Technologies Long Term Debt History

Loading

Dynavax Technologies vs. peers: Long Term Debt Comparison

Loading

Dynavax Technologies Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Dynavax Technologies (DVAX) FAQ

As of the most recent data (September 2025), DVAX shows a long-term debt of $240M. That compares with $250M in the prior-year period — down 2.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DVAX's long-term debt is now $240M (was $250M) — a 2.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Dynavax Technologies is outperforming or lagging.

Tracking DVAX's long-term debt over time shows whether Dynavax Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $250M in the prior-year period — down 2.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Dynavax Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $240M) with ownership activity and broader fundamentals.

Dynavax Technologies's long-term debt is $240M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.